Terry P. Gould is Director & 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS). They have made 4 open-market trades across 3 companies since 2016, most recently 2021-08-02.
CIK 0001553470
4 open-market purchases totalling $13.0M since 2016, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.